| Pharmaceutical active ingredients: |
| Neomycin |
| Available forms, composition and doses of Mycifradin-N: |
| N / A |
| Mycifradin-N medical category: |
| Human:Antibiotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A01AB08 - NeomycinA07AA01 - NeomycinB05CA09 - NeomycinD06AX04 - NeomycinJ01GB05 - NeomycinR02AB01 - NeomycinS01AA03 - NeomycinS02AA07 - NeomycinS03AA01 - Neomycin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mybasan | Isoniazid | Unidentified Pharmaceutical Company |
| My-B-Den | Adenosine Phosphate | Unidentified Pharmaceutical Company |
| Mycasaal | Mefenamic Acid | Unidentified Pharmaceutical Company |
| Mycelax | Clotrimazole | Unidentified Pharmaceutical Company |
| Mychel-Vet | Chloramphenicol | Unidentified Pharmaceutical Company |
| Mycilan | Haloprogin | Unidentified Pharmaceutical Company |
| Mycinol | Chloramphenicol; Malathion | Unidentified Pharmaceutical Company |
| Mycivin | Lincomycin | Unidentified Pharmaceutical Company |
| Mycocuran | Mephenesin | Unidentified Pharmaceutical Company |
| Myconystatin | Nystatin | Unidentified Pharmaceutical Company |